Skip to content
Richard Peek
Home
Contact Me
Publications
Richard Peek
←
A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23
Disease etiology and outcomes after atezolizumab plus bevacizumab in hepatocellular carcinoma: Post-hoc analysis of IMbrave150
→
Hiding in plain sight
Posted on
March 6, 2023
by
Gastroenterology Journal
This entry was posted in
News
. Bookmark the
permalink
.
←
A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23
Disease etiology and outcomes after atezolizumab plus bevacizumab in hepatocellular carcinoma: Post-hoc analysis of IMbrave150
→
Links
Gastroenterology
MyVUMC
March 2023
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Feb
Apr »
Other websites
Etiological Studies of Gastric Carcinoma
H. pylori and Gastric Cancer
